Correlation Between Better Choice and Integrated Biopharma

Can any of the company-specific risk be diversified away by investing in both Better Choice and Integrated Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Better Choice and Integrated Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Better Choice and Integrated Biopharma, you can compare the effects of market volatilities on Better Choice and Integrated Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Better Choice with a short position of Integrated Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Better Choice and Integrated Biopharma.

Diversification Opportunities for Better Choice and Integrated Biopharma

0.21

Correlation Coefficient

Better Choice  Integrated Biopharma

Modest diversification

The 3 months correlation between Better and Integrated is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Better Choice and Integrated Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Integrated Biopharma and Better Choice is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Better Choice are associated (or correlated) with Integrated Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Integrated Biopharma has no effect on the direction of Better Choice i.e., Better Choice and Integrated Biopharma go up and down completely randomly.

Pair Corralation between Better Choice and Integrated Biopharma

Given the investment horizon of 90 days Better Choice is expected to under-perform the Integrated Biopharma. In addition to that, Better Choice is 1.38 times more volatile than Integrated Biopharma. It trades about -0.02 of its total potential returns per unit of risk. Integrated Biopharma is currently generating about 0.01 per unit of volatility. If you would invest  41.00  in Integrated Biopharma on August 10, 2024 and sell it today you would lose (8.00) from holding Integrated Biopharma or give up 19.51% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	33.81%
Values	Daily Returns

Better Choice  vs.  Integrated Biopharma

Better Choice

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Better Choice has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Integrated Biopharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Integrated Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Integrated Biopharma is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Better Choice and Integrated Biopharma

The main advantage of trading using opposite Better Choice and Integrated Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Better Choice position performs unexpectedly, Integrated Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integrated Biopharma will offset losses from the drop in Integrated Biopharma's long position.

The idea behind Better Choice and Integrated Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.